Insider Transactions in Q2 2024 at Certara, Inc. (CERT)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2024
|
Matthew M Walsh |
BUY
Exercise of conversion of derivative security
|
Direct |
8,663
+4.46%
|
-
|
|
May 21
2024
|
Nancy Killefer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,663
+26.39%
|
-
|
|
May 21
2024
|
Rosemary A Crane |
BUY
Exercise of conversion of derivative security
|
Direct |
8,663
+32.51%
|
-
|
|
May 21
2024
|
Cynthia Collins |
BUY
Exercise of conversion of derivative security
|
Direct |
8,663
+26.39%
|
-
|
|
May 21
2024
|
James E Cashman Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
8,663
+1.86%
|
-
|
|
May 21
2024
|
Eran Broshy |
BUY
Exercise of conversion of derivative security
|
Direct |
8,663
+27.34%
|
-
|
|
Apr 02
2024
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
SELL
Open market or private sale
|
Direct |
14,427
-4.07%
|
$245,259
$17.24 P/Share
|
|
Apr 01
2024
|
Nicolette D Sherman CHIEF HUMAN RESOURCES OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-5.34%
|
$43,826
$17.88 P/Share
|
|
Apr 01
2024
|
Nicolette D Sherman CHIEF HUMAN RESOURCES OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,219
+14.54%
|
-
|
|
Apr 01
2024
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
6,955
-3.73%
|
$118,235
$17.88 P/Share
|
|
Apr 01
2024
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
BUY
Exercise of conversion of derivative security
|
Direct |
16,498
+11.34%
|
-
|
|
Apr 01
2024
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,000
-1.7%
|
$54,000
$18.0 P/Share
|
|
Apr 01
2024
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
6,244
-1.19%
|
$106,148
$17.88 P/Share
|
|
Apr 01
2024
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
13,295
+3.63%
|
-
|
|
Apr 01
2024
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
SELL
Payment of exercise price or tax liability
|
Direct |
10,625
-1.22%
|
$180,625
$17.88 P/Share
|
|
Apr 01
2024
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
BUY
Exercise of conversion of derivative security
|
Direct |
16,498
+2.75%
|
-
|
|
Apr 01
2024
|
John E Gallagher CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,077
-25.79%
|
$154,309
$17.88 P/Share
|
|
Apr 01
2024
|
John E Gallagher CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
27,295
+42.95%
|
-
|
|
Apr 01
2024
|
Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF |
SELL
Payment of exercise price or tax liability
|
Direct |
5,951
-1.35%
|
$101,167
$17.88 P/Share
|
|
Apr 01
2024
|
Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF |
BUY
Exercise of conversion of derivative security
|
Direct |
16,498
+5.22%
|
-
|
|
Apr 01
2024
|
William F Feehery CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
42,629
-0.63%
|
$724,693
$17.88 P/Share
|
|
Apr 01
2024
|
William F Feehery CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
69,799
+1.52%
|
-
|